COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - FRA:CBHD - DK0060448595 - Common Stock
78.28 EUR
+2.48 (+3.27%)
Overall CBHD gets a fundamental rating of 5 out of 10. We evaluated CBHD against 60 industry peers in the Health Care Equipment & Supplies industry. While CBHD belongs to the best of the industry regarding profitability, there are concerns on its financial health. CBHD is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
CBHD had a positive operating cash flow in the past year.
In the past 5 years CBHD has always been profitable.
In the past 5 years CBHD always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of CBHD (8.51%) is better than 85.00% of its industry peers.
CBHD's Return On Equity of 24.78% is amongst the best of the industry. CBHD outperforms 93.33% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.96%, CBHD belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBHD is significantly above the industry average of 9.00%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROIC | 15.96% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
CBHD's Profit Margin of 14.62% is amongst the best of the industry. CBHD outperforms 85.00% of its industry peers.
In the last couple of years the Profit Margin of CBHD has declined.
The Operating Margin of CBHD (26.99%) is better than 95.00% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
With a decent Gross Margin value of 67.55%, CBHD is doing good in the industry, outperforming 76.67% of the companies in the same industry.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
CBHD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CBHD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CBHD has been increased compared to 5 years ago.
The debt/assets ratio for CBHD is higher compared to a year ago.
2.2 Solvency
CBHD has an Altman-Z score of 3.94. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
CBHD has a Altman-Z score of 3.94. This is in the better half of the industry: CBHD outperforms 66.67% of its industry peers.
CBHD has a debt to FCF ratio of 4.89. This is a neutral value as CBHD would need 4.89 years to pay back of all of its debts.
CBHD has a Debt to FCF ratio of 4.89. This is comparable to the rest of the industry: CBHD outperforms 60.00% of its industry peers.
A Debt/Equity ratio of 1.05 is on the high side and indicates that CBHD has dependencies on debt financing.
CBHD has a worse Debt to Equity ratio (1.05) than 85.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Altman-Z | 3.94 |
ROIC/WACC2.63
WACC6.07%
2.3 Liquidity
A Current Ratio of 1.00 indicates that CBHD should not have too much problems paying its short term obligations.
CBHD's Current ratio of 1.00 is on the low side compared to the rest of the industry. CBHD is outperformed by 76.67% of its industry peers.
A Quick Ratio of 0.64 indicates that CBHD may have some problems paying its short term obligations.
The Quick ratio of CBHD (0.64) is worse than 78.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.94%.
CBHD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.72% yearly.
Looking at the last year, CBHD shows a small growth in Revenue. The Revenue has grown by 5.95% in the last year.
The Revenue has been growing by 8.54% on average over the past years. This is quite good.
EPS 1Y (TTM)-13.94%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-30.39%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%1.06%
3.2 Future
Based on estimates for the next years, CBHD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.04% on average per year.
Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 6.65% on average per year.
EPS Next Y-2.42%
EPS Next 2Y7.9%
EPS Next 3Y9%
EPS Next 5Y10.04%
Revenue Next Year3.9%
Revenue Next 2Y4.92%
Revenue Next 3Y5.76%
Revenue Next 5Y6.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CBHD is valuated quite expensively with a Price/Earnings ratio of 30.70.
61.67% of the companies in the same industry are more expensive than CBHD, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.11, CBHD is valued at the same level.
The Price/Forward Earnings ratio is 22.36, which indicates a rather expensive current valuation of CBHD.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBHD is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CBHD to the average of the S&P500 Index (22.55), we can say CBHD is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.7 | ||
| Fwd PE | 22.36 |
4.2 Price Multiples
CBHD's Enterprise Value to EBITDA is on the same level as the industry average.
CBHD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.83 | ||
| EV/EBITDA | 16.5 |
4.3 Compensation for Growth
The excellent profitability rating of CBHD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)11.29
EPS Next 2Y7.9%
EPS Next 3Y9%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.73%, CBHD has a reasonable but not impressive dividend return.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 2.13. CBHD pays more dividend than 98.33% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, CBHD pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.73% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
121.67% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP121.67%
EPS Next 2Y7.9%
EPS Next 3Y9%
FRA:CBHD (10/31/2025, 7:00:00 PM)
78.28
+2.48 (+3.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.45B
Revenue(TTM)27.87B
Net Income(TTM)4.08B
Analysts67.69
Price Target92.76 (18.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.73% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP121.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.87%
Min EPS beat(2)-22.36%
Max EPS beat(2)-15.38%
EPS beat(4)0
Avg EPS beat(4)-13.35%
Min EPS beat(4)-22.36%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-10.21%
EPS beat(12)0
Avg EPS beat(12)-8.91%
EPS beat(16)1
Avg EPS beat(16)-7.89%
Revenue beat(2)0
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-2.12%
Max Revenue beat(4)-0.03%
Revenue beat(8)1
Avg Revenue beat(8)-1.52%
Revenue beat(12)1
Avg Revenue beat(12)-1.36%
Revenue beat(16)4
Avg Revenue beat(16)-0.78%
PT rev (1m)-2.1%
PT rev (3m)-8.33%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.9%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-0.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.7 | ||
| Fwd PE | 22.36 | ||
| P/S | 4.41 | ||
| P/FCF | 24.83 | ||
| P/OCF | 19.12 | ||
| P/B | 7.47 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.5 |
EPS(TTM)2.55
EY3.26%
EPS(NY)3.5
Fwd EY4.47%
FCF(TTM)3.15
FCFY4.03%
OCF(TTM)4.1
OCFY5.23%
SpS17.75
BVpS10.48
TBVpS-8.58
PEG (NY)N/A
PEG (5Y)11.29
Graham Number24.52
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROCE | 20.15% | ||
| ROIC | 15.96% | ||
| ROICexc | 16.27% | ||
| ROICexgc | 89.1% | ||
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% | ||
| FCFM | 17.76% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexgc growth 3Y7.74%
ROICexgc growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Debt/EBITDA | 1.95 | ||
| Cap/Depr | 109.63% | ||
| Cap/Sales | 5.31% | ||
| Interest Coverage | 7.46 | ||
| Cash Conversion | 72.46% | ||
| Profit Quality | 121.42% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 3.94 |
F-Score6
WACC6.07%
ROIC/WACC2.63
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.94%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-30.39%
EPS Next Y-2.42%
EPS Next 2Y7.9%
EPS Next 3Y9%
EPS Next 5Y10.04%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%1.06%
Revenue Next Year3.9%
Revenue Next 2Y4.92%
Revenue Next 3Y5.76%
Revenue Next 5Y6.65%
EBIT growth 1Y4.5%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year22.79%
EBIT Next 3Y12.78%
EBIT Next 5Y11.59%
FCF growth 1Y53.38%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y43.32%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 4 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 8 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 3 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to decline by -2.42% in the next year.